Table 5.
Variables | Exercise Group (N = 18) | Control Group (N = 18) | Time p |
Group p |
Time x group interaction p |
Size effect Cohen’d | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline Mean ± SD | 3 months Mean ± SD | 6 months Mean ± SD | 9 months Mean ± SD | Baseline Mean ± SD | 3 months Mean ± SD | 6 months Mean ± SD | 9 months Mean ± SD | |||||
Body image | 77.4 ± 14.7 | 87.7 ± 18.9 | 98.1 ± 3.6*a | 97.1 ± 7.2*a | 73.9 ± 17.8 | 78.9 ± 15.4 | 85.6 ± 19.5 | 73.3 ± 24.8 | 0.001 | 0.006 | 0.01 | 1.30 |
Sexual functioning | 89.2 ± 16.6 | 91.2 ± 22.1 | 87.2 ± 18.2 | 94.1 ± 14.4 | 85.6 ± 26.6 | 90.0 ± 18.7 | 86.7 ± 22.0 | 94.4 ± 14.9 | 0.31 | 0.96 | 0.77 | 0.02 |
Sexual enjoyment | 88.2 ± 28.7 | 88.3 ± 29.0 | 78.4 ± 26.2 | 86.3 ± 26.5 | 93.3 ± 13.8 | 95.6 ± 17.2 | 95.6 ± 17.2 | 93.3 ± 18.7 | 0.66 | 0.41 | 0.16 | 0.31 |
Future Perspective | 54.9 ± 38.9 | 47.1 ± 37.4 | 74.5 ± 27.7 | 78.4 ± 37.1 | 55.5 ± 44.8 | 57.8 ± 36.6 | 55.6 ± 34.9 | 46.6 ± 43.3 | 0.34 | 0.05 | 0.28 | 0.79 |
Systemic therapy side effects | 28.3 ± 15.7 | 12.0 ± 14.9 | 7.8 ± 12.7 | 16.5 ± 14.4 | 34.7 ± 24.8 | 20.1 ± 22.5 | 18.7 ± 15.8 | 22.1 ± 13.1 | < 0.001 | 0.86 | 0.08 | 0.41 |
Breast symptoms | 11.3 ± 12.1 | 4.4 ± 7.8 | 10.8 ± 14.9 | 10.3 ± 12.7 | 14.9 ± 21.5 | 16.2 ± 19.2 | 10.1 ± 18.2 | 11.3 ± 13.3 | 0.72 | 0.25 | 031 | 0.08 |
Arm symptoms | 20.3 ± 19.7 | 12.4 ± 18.4 | 16.9 ± 28.8 | 18.9 ± 15.1 | 27.8 ± 32.8 | 27.8 ± 32.8 | 18.2 ± 21.6 | 24.6 ± 21.7 | 0.58 | 0.53 | 0.23 | 0.30 |
Upset by hair loss | 27.4 ± 39.5 | 9.8 ± 25.7a | 5.9 ± 13.1*a | 17.6 ± 33.6 | 38.1 ± 43.1 | 23.8 ± 42.2 | 30.9 ± 33.2 | 33.3 ± 34.4 | 0.18 | 0.80 | 0.03 | 0.46 |
Note: Post hoc analysis time x group interaction: * = statistically significant difference between groups and a = Bonferroni’s post hoc with p < 0.05 compared to baseline. Values expressed as mean and standard deviation